ALSE Stock UPDATES Alseres Pharmaceutcl (ALSE) 0.0340 08/30/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alseres Pharmaceutcl (ALSE) 0.0340 $ALSE

Elemental Energy Announces Financial Close for 11.2MW Community Wind Portfolio in Nova Scotia
CNW Group - Thu Aug 21, 8:00AM CDT
Elemental Energy Inc. ("Elemental" and its community partners, Watts Wind Energy Inc. and Katalyst Wind Inc., closed non-recourse construction and term debt financing for the 11.2 megawatt ("MW" Watts Wind II Limited Partnership portfolio of wind projects in Nova Scotia. National Bank of Canada (TSX:NA) is the sole lender on the CAD $30 million transaction which was completed on July 31 2014.

Growth Factors (Blood and Tissue) Market 2014 - Global Strategic Business Report
M2 - Thu Aug 14, 2:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bqzzts/growth_factors) has announced the addition of the "Growth Factors (Blood and Tissue) - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Types: - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) - Tissue Growth Factors. The report profiles 90 companies including many key and niche players such as: - Alseres Pharmaceuticals, Inc. - Amgen, Inc. - Bayer HealthCare Pharmaceuticals, Inc. - Biogen Idec Inc - BioMimetic Therapeutics, Inc. - Biopharm GmbH - Bolder Biotechnology, Inc. - F. Hoffmann-La Roche Ltd - Chugai Pharmaceutical Co. Ltd. - Genentech, Inc. - FibroGen, Inc. - Johnson & Johnson - Janssen Biotech, Inc. - Lonza Group - Merck Serono International S.A. - NsGene A/S - PeproTech, Inc. - Reliance GeneMedix Plc - Sangamo BioSciences, Inc. - Sanofi - Shantha Biotechnics - Scil Proteins GmbH - Wockhardt Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Growth Factors An Overview 3. Research Studies & Clinical Trials 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 90 (including Divisions/Subsidiaries 95) - The United States (42) - Japan (8) - Europe (19) - France (1) - Germany (8) - The United Kingdom (1) - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (24) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/bq...th_factors

Nova Scotia Power Inc. Approves Preferred Share Quarterly Dividend
Business Wire - Fri Jul 04, 9:21AM CDT
On July 4, 2014 the Board of Directors of Nova Scotia Power Inc. (TSX: NSI.PR.D) approved a quarterly dividend of $0.36875 per Nova Scotia Power Incorporated Series D First Preferred Share payable on and after October 15, 2014 to Series D preferred shareholders of record October 1, 2014.

Travelers Capital Corporation Arranges Project Financing for 24 MW Wind Energy Project Portfolio in Nova Scotia
CNW Group - Fri Jun 13, 4:42PM CDT
Travelers Capital Corporation is pleased to announce that it has successfully arranged $57 million of non-recourse project financing for a portfolio of four wind energy projects in Nova Scotia aggregating 24 MW (the "Projects" . The Projects were developed by juwi Wind Canada and sold its minority or majority control in each Project to Firelight Infrastructure Partners prior to construction. The Projects consist of the following:

Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica

Nova Scotia Power approves preferred share dividend of CAD0.37
M2 - Thu Feb 06, 5:21AM CST
The board of directors of an electric utility company, Nova Scotia Power Inc (TSX:NSI.PR.D), based in Canada, authorised a quarterly dividend of CAD0.37 per share on its series D first preferred share, the company declared on Wednesday.

Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
M2 - Fri Aug 02, 9:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xckkfp/radiopharmaceutica#summary) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Key Topics Covered: Click the link below to view the full extended table of contents and list of companies featured. I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - - France (2) - - Germany (2) - - The United Kingdom (4) - - Italy (2) - - Spain (1) - - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/xc...ca#summary

Nova Scotia Power Inc. Issues $300 Million ofMedium Term Notes
Business Wire - Fri Jul 19, 8:59AM CDT
Today, Nova Scotia Power Inc. completed the issue of $300 million Series Z Medium Term Notes. The Series Z Notes bear interest at the rate of 4.50% and yield 4.537% per annum until July 20, 2043.

Nova Scotia Power's board approves USD0.36875 quarterly preferred share dividend
M2 - Mon Jul 08, 4:26AM CDT
The board of directors of Nova Scotia Power Inc (TSX:NSI.PR.D) on Friday announced the approval of quarterly dividend of USD0.36875 per Nova Scotia Power Incorporated Series D first preferred share.

Nova Scotia Power announces quarterly dividend of USD0.36875 per share on its preferred stock
M2 - Mon Jul 08, 3:06AM CDT
The board of directors of Nova Scotia Power Inc (TSX:NSI.PR.D), a provider of electricity generation, transmission and distribution services, authorised series D first preferred stock dividends of USD0.36875 per share, the company declared on Friday.

Nova Scotia Power announces series D preferred dividend of USD0.36875 per share
M2 - Thu Feb 07, 4:36AM CST
The board of directors of Nova Scotia Power Inc (TSX:NSI.PR.D), an electricity provider, has authorised a series D first preferred dividend of USD0.36875 per share for the quarter ending 31 March 2013, the company declared on Wednesday.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 347

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 37

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading

Top 5 Most Recently Viewed Articles

Westlake Chemical Partners Schedules Q4 and Year-End Call

Updated Category News Views 158

Westlake Chemical Partners to Announce Earnings Soon Westlake Chemical Partners (NYSE: WLKP), based in Houston, is preparing to release its earnings report for the fourth quarter and full year 2024. This significant announcement is eagerly anticipated by investors and industry analysts alike. The earnings report is scheduled to be released prior to the market opening on a...

Continue Reading
Wabtec's Bold Move: Acquiring Evident's Tech Division

Updated Category News Views 144

Wabtec's Strategic Acquisition of Evident's Inspection Technologies Wabtec Corp, a leader in heavy industrial parts manufacturing, has made headlines with its recent decision to acquire the inspection technologies division of Evident for an impressive $1.78 billion. This acquisition reflects Wabtec's strategy to enhance its portfolio and strengthen its position within the...

Continue Reading
Insight into WisdomTree's Latest Fund Valuations

Updated Category News Views 184

Understanding Net Asset Values in ETFs Investors often seek knowledge about the net asset values (NAVs) of Exchange Traded Funds (ETFs), which play a critical role in determining how funds are valued and traded in the market. For instance, WisdomTree Issuer plc regularly offers updates concerning its funds, revealing the intricate details behind price fluctuations and...

Continue Reading
Investigation Announced Into Electronic Systems Technology, Inc.

Updated Category News Views 239

Investigation of Electronic Systems Technology, Inc. In a noteworthy development, the M&A Class Action Firm has announced an investigation into Electronic Systems Technology, Inc. (OTCMKTS: ELST). This firm, recognized as a top competitor in the 2024 ISS Securities Class Action Services Report, is dedicated to protecting shareholder interests. The firm, led by renowned...

Continue Reading
Fusion CBD Products Partners with Major League Baseball Teams

Updated Category News Views 291

Fusion CBD Products and Major League Baseball: A Growing Partnership Team sponsorship opportunities expand as the league embraces CBD's advantages. As the Major League Baseball (MLB) season unfolds, many players are facing injuries from early training sessions and games. Notable players like Heliot Ramos of the San Francisco Giants and Erik Miller have recently dealt with...

Continue Reading